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Background
Targeting Dendritic Cells (DCs) with anti-DC receptor
antibody-antigen fusion proteins is a novel approach in
vaccine development for inducing potent humoral and
cellular immune responses.
Methods
We engineered an anti-human DCIR recombinant anti-
body cross-reacting with the cynomolgus macaque recep-
tor fused via the heavy chain C-terminus to HIV-1
Gagp24 protein (anti-DCIR.Gagp24). HIV patient PBMC
cultures were incubated with anti-DCIR and control
hIgG4.Gagp24 fusion proteins. After 10 days, the total T
cells were challenged with HIV Gagp24 peptide pools, and
then antigen-specific cytokine production was detected
using intracellular staining. Macaques were also immu-
nized i.d. 3 times with anti-DCIR.Gagp24 or control
hIgG4.Gagp24 with or without polyI:C. Gagp24-specific
IgG titers from serum were measured by ELISA and the
magnitude of the antigen-specific IFNg responses was
assessed by ELISPOT.
Results
In vitro, low doses of anti-DCIR Gagp24 prototype vac-
cine, but not the control hIgG4.Gagp24, expand of
Gagp24-specific T cells. These in vitro-expanded anti-
gen-specific T cells were multifunctional, simultaneously
producing multiple cytokines (IFNg, TNFa and MIP-1b).
In vivo, in non-adjuvanted naïve animals, serum anti-
Gagp24 antibodies were detectable 2 weeks after priming
and titers were substantially increased after the 1st and
the 2nd boost with anti-DCIR.Gagp24 and were durable,
while in the control hIgG4.Gagp24 group the responses
were minimal. Poly I:C increased the magnitude of the
responses in the anti-DCIR.Gagp24 and hIgG4.Gagp24
groups to a similar level in both groups. T cell responses
induced by anti-DCIR Gagp24 could be enhanced after
priming with a recombinant modified vaccinia virus
Ankara (MVA) encoding HIV Gag/Pol/Nef. Boosting
with anti-DCIR.Gagp24 plus poly I:C generated high
titers of anti-Gagp24 antibody titers and strongly
enhanced IFNg-producing T cells following priming with
MVA HIV Gag/Pol/Nef.
Conclusion
Our results demonstrate that heterologous prime-boost
immunization with vectors and DC-targeting protein-
based vaccines is a promising vaccination approach to
optimize humoral and cellular immunity for therapeutic
and preventive applications against AIDS.
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